The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Karp, D. D., Paz-Ares, L. G., Novello, S., Haluska, P., Garland, L., Cardenal, F., Blakely, L. J., Eisenberg, P. D., Langer, C. J., Blumenschein, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9331 · Cited by 260
Self-citationRetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Self-citationPlasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Self-citationThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Self-citationLamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)
Lu, Y., Zi, X., Zhao, Y., Mascarenhas, D., & Pollak, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1852 · Cited by 882
Self-citationRapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755
Gastrosplenic Fistula From Hodgkin's Lymphoma
Seib, C. D., Rocha, F. G., Hwang, D. G., & Shoji, B. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7695 · Cited by 735
Epidermal Growth Factor Receptor Targeting in Cancer
MENDELSOHN, J., & BASELGA, J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.003 · Cited by 693
The IGF‐1 receptor in cancer biology
Baserga, R., Peruzzi, F., & Reiss, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11487 · Cited by 642
Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., & Baserga, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11217 · Cited by 553
Guix, M., Faber, A. C., Wang, S. E., Olivares, M. G., Song, Y., Qu, S., Rinehart, C., Seidel, B., Yee, D., Arteaga, C. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34588 · Cited by 521
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Russo, V. C., Gluckman, P. D., Feldman, E. L., & Werther, G. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0024 · Cited by 492
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Chitnis, M. M., Yuen, J. S. P., Protheroe, A. S., Pollak, M., & Macaulay, V. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4879 · Cited by 445
Self-citationMa, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
Self-citationLaw, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y. C., Stratford, A. L., Park, E., Gee, J. M. W., Finlay, P., Jones, H. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2755 · Cited by 401
Self-citationGrowth Patterns and the Risk of Breast Cancer in Women
Ahlgren, M., Melbye, M., Wohlfahrt, J., & Sørensen, T. I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040576 · Cited by 393
Cohen, B. D., Baker, D. A., Soderstrom, C., Tkalcevic, G., Rossi, A. M., Miller, P. E., Tengowski, M. W., Wang, F., Gualberto, A., Beebe, J. S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1070 · Cited by 365
Self-citationCyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth
Girnita, A., Girnita, L., Prete, F. D., Bartolazzi, A., Larsson, O., & Axelson, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2522 · Cited by 363
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 320
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 314
Tolcher, A. W., Mita, M., Meropol, N. J., von Mehren, M., Patnaik, A., Padavic, K., Hill, M., Mays, T., McCoy, T., Fox, N. L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8898 · Cited by 314
Quantitative Mass Spectrometry Identifies Insulin Signaling Targets in C. elegans
Dong, M.-Q., Venable, J. D., Au, N., Xu, T., Park, S. K., Cociorva, D., Johnson, J. R., Dillin, A., & Yates, J. R. (2007) · Science · doi:10.1126/science.1139952 · Cited by 312
Integrated Profiling of Basal and Luminal Breast Cancers
Adélaïde, J., Finetti, P., Bekhouche, I., Repellini, L., Geneix, J., Sircoulomb, F., Charafe-Jauffret, E., Cervera, N., Desplans, J., Parzy, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2536 · Cited by 297
Haluska, P., Shaw, H. M., Batzel, G. N., Yin, D., Molina, J. R., Molife, L. R., Yap, T. A., Roberts, M. L., Sharma, A., Gualberto, A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1118 · Cited by 270
Self-citationTarn, C., Rink, L., Merkel, E., Flieder, D., Pathak, H., Koumbi, D., Testa, J. R., Eisenberg, B., von Mehren, M., & Godwin, A. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803383105 · Cited by 252
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Belfiore, A. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249173 · Cited by 252
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Tolcher, A. W., Mita, A., Lewis, L. D., Garrett, C. R., Till, E., Daud, A. I., Patnaik, A., Papadopoulos, K., Takimoto, C., Bartels, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2064 · Cited by 238
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231 · cited 1×
“There is also evidence that high insulin secretion is associated with adverse prognosis (Goodwin et al., 2002; Ma et al., 2008; Pollak, 2008a; Wolpin et al., 2009).”
BackgroundTao, Y., Pinzi, V., Bourhis, J., & Deutsch, E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0934 · Cited by 230
Insulin receptor expression by human prostate cancers
Cox, M. E., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O., Fazli, L., & Pollak, M. (2009) · The Prostate · doi:10.1002/pros.20852 · Cited by 223
Self-citationDifferential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.
Lammers, R., Gray, A., Schlessinger, J., & Ullrich, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03517.x · Cited by 221
Buck, E., Eyzaguirre, A., Rosenfeld-Franklin, M., Thomson, S., Mulvihill, M., Barr, S., Brown, E., O'Connor, M., Yao, Y., Pachter, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6720 · Cited by 208
Benyoucef, S., Surinya, K. H., Hadaschik, D., & Siddle, K. (2007) · Biochemical Journal · doi:10.1042/bj20061709 · Cited by 203
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
de Bono, J. S., Attard, G., Adjei, A., Pollak, M. N., Fong, P. C., Haluska, P., Roberts, L., Melvin, C., Repollet, M., Chianese, D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0268 · Cited by 192
Self-citationIGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
Weroha, S. J., & Haluska, P. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9104-6 · Cited by 178
Wu, J. D., Odman, A., Higgins, L. M., Haugk, K., Vessella, R., Ludwig, D. L., & Plymate, S. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1586 · Cited by 167
Huang, F., Greer, A., Hurlburt, W., Han, X., Hafezi, R., Wittenberg, G. M., Reeves, K., Chen, J., Robinson, D., Li, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0835 · Cited by 164
del Rincon, J.-P., Iida, K., Gaylinn, B. D., McCurdy, C. E., Leitner, J. W., Barbour, L. A., Kopchick, J. J., Friedman, J. E., Draznin, B., & Thorner, M. O. (2007) · Diabetes · doi:10.2337/db06-0299 · Cited by 164
The insulin-like growth factor 1 receptor in cancer: Old focus, new future
Hartog, H., Wesseling, J., Boezen, H. M., & van der Graaf, W. T. A. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.05.021 · Cited by 163
Lacy, M. Q., Alsina, M., Fonseca, R., Paccagnella, M. L., Melvin, C. L., Yin, D., Sharma, A., Enriquez Sarano, M., Pollak, M., Jagannath, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9319 · Cited by 163
Self-citationZhang, H., Pelzer, A. M., Kiang, D. T., & Yee, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1712 · Cited by 162
Rodon, J., DeSantos, V., Ferry, R. J., & Kurzrock, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0265 · Cited by 162
Mechanisms of Steroid Impairment of Growth
Hochberg, Z. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064764 · Cited by 159
Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density
Diorio, C., Pollak, M., Byrne, C., Mâsse, B. R., Hébert‐Croteau, N., Yaffe, M. J., Côté, G., Bérubé, S., Morin, C., & Brisson, J. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0706 · Cited by 154
Self-citationJi, Q., Mulvihill, M. J., Rosenfeld-Franklin, M., Cooke, A. R., Feng, L., Mak, G., O’Connor, M., Yao, Y., Pirritt, C., Buck, E. A., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0070 · Cited by 152
Cao, L., Yu, Y., Darko, I., Currier, D. G., Mayeenuddin, L. H., Wan, X., Khanna, C., & Helman, L. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1712 · Cited by 148
Benini, S., Manara, M. C., Baldini, N., Cerisano, V., Serra, M., Mercuri, M., Lollini, P., Nanni, P., Picci, P., & Scotlandi, K. (2001) · PubMed · Cited by 141
Myal, Y., Shiu, R. P. C., Bhaumick, B., & Bala, M. (1984) · PubMed · Cited by 138
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
Hyun, T. S., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J. S., & Li, W. (2000) · Blood · doi:10.1182/blood.v96.10.3560 · Cited by 137
Presence of somatomedin receptors on primary human breast and colon carcinomas
Pollak, M., Perdue, J. F., Margolese, R. G., Baer, K. A., & Richard, M. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90218-7 · Cited by 136
Self-citationReduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
Pollak, M., Blouin, M.-J., Zhang, J.-C., & Kopchick, J. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1895 · Cited by 123
Self-citationTargeting the type 1 insulin-like growth factor receptor as a treatment for cancer
Yuen, J. S. P., & Macaulay, V. M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.589 · Cited by 120
Sachdev, D., Singh, R., Fujita‐Yamaguchi, Y., & Yee, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3126 · Cited by 119
Targeting insulin-like growth factor pathways
Yee, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602963 · Cited by 114
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
Klinakis, A., Szabolcs, M. J., Chen, G., Xuan, S., Hibshoosh, H. H., & Efstratiadis, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810221106 · Cited by 99
Insulin-like Growth Factor-I Receptor Signaling Blockade Combined with Radiation
Allen, G. W., Saba, C., Armstrong, E. A., Huang, S., Benavente, S., Ludwig, D. L., Hicklin, D. J., & Harari, P. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2000 · Cited by 94
Morrow, L., O'Brien, M. B., Moller, D. E., Flier, J. S., & Moses, A. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027228 · Cited by 88
Clinical implications of the reduced activity of the GH-IGF-I axis in older men.
Ceda, G. P., Dall’Aglio, E., Maggio, M. G., Lauretani, F., Bandinelli, S., Falzoi, C., Grimaldi, W., Ceresini, G., Corradi, F., Ferrucci, L., et al. (2005) · PubMed · Cited by 87
Wiseman, L. R., Johnson, M. D., Wakeling, A. E., Lykkesfeldt, A. E., May, F. E. B., & Westley, B. R. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90218-5 · Cited by 87
Wu, J. D., Haugk, K. H., Coleman, I. M., Woodke, L. B., Vessella, R. L., Nelson, P. S., Montgomery, B., Ludwig, D. L., & Plymate, S. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0443 · Cited by 84
Higano, C. S., Yu, E. Y., Whiting, S. H., Gordon, M. S., LoRusso, P. M., Fox, F. E., Katz, T. L., Roecker, J., & Schwartz, J. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3505 · Cited by 80
Martin, M. J., Melnyk, N., Pollard, M., Bowden, M., Leong, Podor, T., Gleave, M., & Sorensen, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1754-1769.2006 · Cited by 79
Tolcher, A. W., Rothenberg, M. L., Rodon, J. A., Delbeke, D., Patnaik, A., Nguyen, L. T., Young, F. M., Hwang, Y. J., Haqq, C., & Puzanov, I. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3002 · Cited by 74
Plymate, S. R., Haugk, K. H., Coleman, I. M., Woodke, L. B., Vessella, R. L., Nelson, P. S., Montgomery, B., Ludwig, D. L., & Wu, J. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0648 · Cited by 61
Majeed, N., Blouin, M., Kaplan‐Lefko, P. J., Barry-Shaw, J., Greenberg, N. M., Gaudreau, P., Bismar, T. A., & Pollak, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208572 · Cited by 56
Self-citationAtzori, F., Tabernero, J. M., Cervantes, A. M. R., Botero, M., Hsu, K., Brown, H. M., Hanley, W. D., Macarulla, T. M., Roselló, S., & Baselga, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3519 · Cited by 56
Cortes, J. E., PAQUETTE, R. L., Talpaz, M., Pinilla, J., Asatiani, E., Wetzler, M., Lipton, J. H., Kasap, C., Bui, L. A., Clary, D. O., et al. (2008) · Blood · doi:10.1182/blood.v112.11.3232.3232 · Cited by 50
Hidalgo, M., Gomez, M. T., Lewis, N. L., Vuky, J., Taylor, G., Hayburn, J. L., Hsu, K., Kosh, M., & Picozzi, V. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3520 · Cited by 46
Rodon, J. A., Patnaik, A., Stein, M. N., Tolcher, A. W., Ng, C. M., Dias, C., Kurman, M. R., Greig, G., Kurzrock, R., & Rubin, E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3590 · Cited by 44
Olmos, D., Okuno, S., Schuetze, S. M., Paccagnella, M. L., Yin, D., Gualberto, A., Worden, F. P., Haluska, P., Bono, J. S. D., & Scurr, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.10501 · Cited by 42
Self-citationBerry, S. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3224 · Cited by 36
Tolcher, A. W., Patnaik, A., Till, E., Takimoto, C. H. M., Papadopoulos, K. P., Massard, C., Méry-Mignard, D., Deslandes, A., Ozoux, M., & Soria, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3582 · Cited by 32
Sarantopoulos, J., Mita, A. C., Mulay, M., Romero, O., Lu, J., Capilla, F., Chen, L., Hwang, Y. J., Friberg, G. R., & Rosen, L. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3583 · Cited by 31
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma.
Moreau, P., Hulin, C., Facon, T. T. F., Boccadoro, M., Méry-Mignard, D., Deslandes, A., & Harousseau, J. (2007) · Blood · doi:10.1182/blood.v110.11.1166.1166 · Cited by 30
Monoclonal antibodies against components of the IGF system for cancer treatment.
Feng, Y., & Dimitrov, D. S. (2008) · PubMed · Cited by 27
Characterization of NSCLC patients responding to anti-IGF-IR therapy
Gualberto, A., Melvin, C. L., Dean, A., Ang, A. L., Reynolds, J. M., Lee, A., Terstappen, L. W. M. M., Haluska, P., Lipton, A., & Karp, D. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.8000 · Cited by 24
Self-citationLindsay, C. R., Chan, E., Evans, T. R. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.2559 · Cited by 20
Rothenberg, M. L., Poplin, E. A., Sandler, A. B., Rubin, E., Fox, F. E., Schwartz, J., VerMeulen, W. L., & Youssoufian, H. (2007) · Molecular Cancer Therapeutics · Cited by 19
Yin, D., Paccagnella, M. L., Lacy, M. Q., Bono, J. S. D., Haluska, P., Gualberto, A., & Sharma, A. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2524 · Cited by 8
Self-citation
Cited by
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Self-citationTargeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Clayton, P. E., Banerjee, I., Murray, P. G., & Renehan, A. G. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.171 · Cited by 364
Lee, C., & Longo, V. D. (2011) · Oncogene · doi:10.1038/onc.2011.91 · Cited by 303
Livingstone, C. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0231 · Cited by 296
Metadata
- Authors
- Gualberto, A., & Pollak, M.
- Venue
- Oncogene
- Published
- 2009-07-06
- Volume
- 28
- Issue
- 34
- Pages
- 3009-3021
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2094025115
- Cited by
- 274
- References
- 89
- FWCI
- 29.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.